Papers

1

Total Citations

4

H-Index

1

About

Dr. Sunati Sahoo is a pioneering surgical oncologist whose research focuses on advancing breast cancer treatment through innovative, less invasive approaches. Her most notable contribution is the development and clinical evaluation of single-fraction ablative radiotherapy for early-stage breast cancer, a paradigm-shifting technique that compresses weeks of conventional radiation into a single, targeted pre-operative dose. As lead author of the landmark Phase I trial published in 2023, Dr. Sahoo demonstrated the safety and feasibility of this approach, achieving 4 citations in its early dissemination—a promising start for a transformative protocol that could redefine surgical and radiation standards. Her work aims to reduce treatment burden, minimize toxicity, and improve cosmetic outcomes for patients, directly addressing critical gaps in breast-conserving therapy. Dr. Sahoo’s research bridges surgical oncology and radiation oncology, positioning her as a key figure in the movement toward personalized, de-escalated breast cancer care. With a growing portfolio of clinical trials and translational studies, she continues to shape the future of early-stage breast cancer management, making her a vital resource for students and researchers interested in innovative oncologic interventions.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Early Results of a Phase I Pre-Operative Single Fraction Ablative Trial for Early Stage Breast Cancer
4 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: The University of Texas Southwestern Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago